Pro‐Inflammatory Biomarkers in Stable Versus Acutely Decompensated Heart Failure With Preserved Ejection Fraction
BackgroundUnderlying inflammation has been increasingly recognized in heart failure with a preserved ejection fraction (HFpEF). In this study we tested the hypothesis that pro‐inflammatory biomarkers are elevated in patients with acutely decompensated HFpEF (AD‐HFpEF) compared with patients with sta...
Autores principales: | Abraham Abernethy, Sadi Raza, Jie‐Lena Sun, Kevin J. Anstrom, Russell Tracy, Johannes Steiner, Peter VanBuren, Martin M. LeWinter |
---|---|
Formato: | Artículo |
Lenguaje: | English |
Publicado: |
Wiley
2018-04-01
|
Colección: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
Materias: | |
Acceso en línea: | https://www.ahajournals.org/doi/10.1161/JAHA.117.007385 |
Ejemplares similares
-
Do we need a definition of acute heart failure with preserved ejection fraction?
por: Agnieszka Kapłon-Cieślicka, et al.
Publicado: (2021-01-01) -
Heart failure with preserved ejection fraction (HFpEF): Implications for the anesthesiologists
por: Ajmer Singh, et al.
Publicado: (2018-01-01) -
Soluble ST2 in Heart Failure With Preserved Ejection Fraction
por: Omar F. AbouEzzeddine, et al.
Publicado: (2017-02-01) -
Cell Therapy for Heart Failure With Preserved Ejection Fraction∗
por: Barry A. Borlaug, MD, et al.
Publicado: (2016-01-01) -
Common Heart Failure With Preserved Ejection Fraction Animal Models Yield Disparate Myofibril Mechanics
por: Axel J. Fenwick, et al.
Publicado: (2024-01-01)